Cited by 788Cannabis and Cannabinoid ResearchRegulation of Appetite and ObesityEating Disorders and Behaviors

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

Open access
Kirkham, Tim C, Williams, Claire M, Fezza, Filomena, Marzo, Vincenzo Di·2002·British Journal of Pharmacology

Abstract

Endocannabinoids are implicated in appetite and body weight regulation. In rodents, anandamide stimulates eating by actions at central CB1 receptors, and hypothalamic endocannabinoids may be under the negative control of leptin. However, changes to brain endocannabinoid levels in direct relation to feeding or changing nutritional status have not been investigated. We measured anandamide and 2-arachidonoyl glycerol (2-AG) levels in feeding-associated brain regions of rats, during fasting, feeding of a palatable food, or after satiation. Endocannabinoid levels were compared to those in rats fed ad libitum, at a point in their daily cycle when motivation to eat was absent. Fasting increased levels of anandamide and 2-AG in the limbic forebrain and, to a lesser extent, of 2-AG in the hypothalamus. By contrast, hypothalamic 2-AG declined as animals ate. No changes were detected in satiated rats. Endocannabinoid levels in the cerebellum, a control region not directly involved in the control of food intake, were unaffected by any manipulation. As 2-AG was most sensitive to variation during feeding, and to leptin regulation in a previous study, we examined the behavioural effects of 2-AG when injected into the nucleus accumbens shell, a limbic forebrain area strongly linked to eating motivation. 2-AG potently, and dose-dependently, stimulated feeding. This effect was attenuated by the CB1 receptor antagonist SR141716. These findings provide the first direct evidence of altered brain levels of endocannabinoids, and of 2-AG in particular, during fasting and feeding. The nature of these effects supports a role for endocannabinoids in the control of appetitive motivation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0704767

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. LE FUR, G., ARNONE, M., RINALDI-CARMONA, M., BARTH, F. & HESHMATI, H. (2001). SR141716, a selective antagonist of CB1 receptors and obesity. Symposium on the Cannabinoids, Burlington, Vermont. International Cannabinoid Research Society, pp 101.

Cited by

Sorted by citations

Authors
Kirkham, T. C., Williams, C. M., Fezza, F., & Marzo, V. D.
Affiliations
  • University of Reading (GB)
  • Istituto di Chimica Biomolecolare (IT)
Corresponding author
Kirkham, Tim C
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2002-06
Volume
136
Issue
4
Pages
550-557
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1963482720
Cited by
788
References
57
Citations by year
2026: 9 · 2025: 21 · 2024: 17 · 2023: 17 · 2022: 18 · 2021: 34 · 2020: 20 · 2019: 32 · 2018: 34 · 2017: 33 · 2016: 23 · 2015: 37 · 2014: 32 · 2013: 25 · 2012: 34
FWCI
15.93
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Directorate for Biological Sciences
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
Keywords
endocannabinoids, 2-arachidonoylglycerol, anandamide, appetite regulation, feeding behavior, fasting, satiation, hypothalamus, limbic forebrain, nucleus accumbens shell, CB1 receptor, SR141716, leptin, eating motivation, palatable food
MeSH terms
Animals, Arachidonic Acids, Fasting, Feeding Behavior, Glycerides, Hypothalamus, Limbic System, Male, Satiation, Rats, Polyunsaturated Alkamides, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review